CLASS III ONGOING Device recall · Reported 12 Jul 2023 · FDA Enforcement Report

NeuMoDx Sars-CoV-2 Assay -Ivd intended recalled by NeuMoDx Molecular

NeuMoDx Molecular is recalling NeuMoDx Sars-CoV-2 Assay -Ivd intended for the qualitative detection of Sars-CoV-2 RNA, distributed nationwide in the US. The recall was initiated on 15 May 2023 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesGTIN: 10814278021264 Lot Number: 123909 Exp. Date: 08-Dec-2023
Quantity recalled1,086 test strips

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2093-2023
FDA event ID
92490
Recalling firm
NeuMoDx Molecular, Ann Arbor, MI
Classification
Class III
Status
Ongoing
Recall initiated
15 May 2023
FDA classified
5 Jul 2023
Reported
12 Jul 2023
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Potency & Assay

Timeline

15 May 2023Recall initiated by company
5 Jul 2023Classified by FDA+51 days
12 Jul 2023Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Potential for lot number discrepancies between the test strip packaging and the barcode label applied to the test strip that is read by the instrument for LOT 123909 of NeuMoDx SARS-CoV-2 Test Strips (REF 300800). The instrument registers the non-human readable text as lot number 123910 from the barcode label.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

NeuMoDx SARS-CoV-2 Assay -IVD intended for the qualitative detection of SARS-CoV-2 RNA from nasal, nasopharyngeal and oropharyngeal swabs in transport medium and bronchoalveolar lavage (BAL) specimens from individuals suspected of COVID-19 by their healthcare provider (HCP). REF Number: 300800

Where it was distributed

US Nationwide distribution in the states of FL, MI, NM, NY, TN, TX.

Nationwide FloridaMichiganNew MexicoNew YorkTennesseeTexas

Questions about this recall

Is NeuMoDx Sars-CoV-2 Assay -Ivd intended for the qualitative detection of Sars-CoV-2 RNA recalled?

Yes. NeuMoDx Molecular recalled NeuMoDx Sars-CoV-2 Assay -Ivd intended for the qualitative detection of Sars-CoV-2 RNA on 15 May 2023. The recall is Class III and its status is Ongoing. Recall number Z-2093-2023.

Why was it recalled?

Potential for lot number discrepancies between the test strip packaging and the barcode label applied to the test strip that is read by the instrument for LOT 123909 of NeuMoDx SARS-CoV-2 Test Strips (REF 300800). The instrument registers the non-human readable text as lot number 123910 from the barcode label.

Which lots are affected?

GTIN: 10814278021264 Lot Number: 123909 Exp. Date: 08-Dec-2023

Where was it sold?

US Nationwide distribution in the states of FL, MI, NM, NY, TN, TX.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from NeuMoDx Molecular

All 6

Other Test Kits & Diagnostics recalls

All 2,656